BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36240246)

  • 1. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
    J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Related Changes in the Nasopharyngeal Microbiome Are Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Symptoms Among Children, Adolescents, and Young Adults.
    Hurst JH; McCumber AW; Aquino JN; Rodriguez J; Heston SM; Lugo DJ; Rotta AT; Turner NA; Pfeiffer TS; Gurley TC; Moody MA; Denny TN; Rawls JF; Clark JS; Woods CW; Kelly MS
    Clin Infect Dis; 2022 Aug; 75(1):e928-e937. PubMed ID: 35247047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
    Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection.
    Crovetto F; Selma-Royo M; Crispi F; Carbonetto B; Pascal R; Larroya M; Casas I; Tortajada M; Escudero N; Muñoz-Almagro C; Gomez-Roig MD; González-Torres P; Collado MC; Gratacos E
    Sci Rep; 2022 Aug; 12(1):13404. PubMed ID: 35927569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
    Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
    Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
    Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
    Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
    Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring nasopharyngeal microbiota profile in children affected by SARS-CoV-2 infection.
    Romani L; Del Chierico F; Pane S; Ristori MV; Pirona I; Guarrasi V; Cotugno N; Bernardi S; Lancella L; Perno CF; Rossi P; Villani A; Campana A; Palma P; Putignani L;
    Microbiol Spectr; 2024 Mar; 12(3):e0300923. PubMed ID: 38289047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types.
    Gupta A; Karyakarte R; Joshi S; Das R; Jani K; Shouche Y; Sharma A
    Microbes Infect; 2022 Feb; 24(1):104880. PubMed ID: 34425246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition.
    Braun T; Halevi S; Hadar R; Efroni G; Glick Saar E; Keller N; Amir A; Amit S; Haberman Y
    Sci Rep; 2021 Apr; 11(1):8922. PubMed ID: 33903709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific nasopharyngeal Corynebacterium strains serve as gatekeepers against SARS-CoV-2 infection.
    Szabo D; Ostorhazi E; Stercz B; Makra N; Penzes K; Kristof K; Antal I; Rethelyi JM; Zsigmond RI; Birtalan E; Merkely B; Tamas L
    Geroscience; 2023 Oct; 45(5):2927-2938. PubMed ID: 37338780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home.
    Rocafort M; Henares D; Brotons P; Launes C; Fernandez de Sevilla M; Fumado V; Barrabeig I; Arias S; Redin A; Ponomarenko J; Mele M; Millat-Martinez P; Claverol J; Balanza N; Mira A; Garcia-Garcia JJ; Bassat Q; Jordan I; Muñoz-Almagro C
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.